| Literature DB >> 35003468 |
Nguyen Duy Anh1,2, Nguyen Xuan Hai1, Nguyen-Thi Thu Ha3, Nguyen Khac Toan4,5, Phan-Thi Huyen Thuong6, Nguyen Minh Duc7,8.
Abstract
Retroperitoneal ectopic pregnancy (REP) is a rare obstetric condition caused by the mislocalization of the gestational mass. The unexpected location often results in missed or delayed diagnoses, which can complicate the treatment process. We report the case of a 34-year-old Asian woman who presented to the hospital 31 days after embryo transfer with mild vaginal bleeding. A history of bilateral salpingectomies was established. Two operations were performed before we were able to successfully remove the gestational sac from the retroperitoneal cavity. The histologic finding suggested an interesting migration pathway for the pregnancy. REP should be considered when a visible gestational sac cannot be detected on ultrasound in the expected locations, particularly among patients who undergo treatment using assisted reproductive techniques (ART), and have a history of bilateral salpingectomies. Magnetic resonance imaging (MRI) plays a vital role in diagnosing REP and guiding surgical interventions. A multidisciplinary team is necessary to treat REP, and monitoring beta-human chorionic gonadotropin (βHCG) levels and histologic findings remain essential during follow-up.Entities:
Keywords: Bilateral salpingectomy; In vitro fertilization; Laparoscopy; MRI; Retroperitoneal ectopic pregnancy
Year: 2021 PMID: 35003468 PMCID: PMC8718810 DOI: 10.1016/j.radcr.2021.12.011
Source DB: PubMed Journal: Radiol Case Rep ISSN: 1930-0433
Fig. 1The first histologic result shows only endometrium tissue and endometriosis.
Fig. 2Magnetic resonance imaging (MRI) findings revealed a suspected gestational sac next to the right common iliac artery (the arrow indicates the location of the retroperitoneal ectopic pregnancy).
Fig. 3The second histologic finding identified the trophoblastic invasion of lymphatic tissue (star indicates lymphatic tissue, arrow indicates trophoblast cells).
Fig. 4Changes in the patient's beta-human chorionic gonadotropin (βHCG) levels.